- Home
- NPCT vs RCS Comparison
NPCT vs RCS Comparison
Compare NPCT & RCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Company Overview
Basic Information| Metric | NPCT | RCS |
|---|---|---|
| Founded | 2020 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Investment Managers |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 286.7M | 246.0M |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | NPCT | RCS |
|---|---|---|
| Price | $9.71 | $5.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 97.7K | ★ 119.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 9.82% | ★ 10.12% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.60 | $5.09 |
| 52 Week High | $11.12 | $8.00 |
Technical Indicators
Market Signals| Indicator | NPCT | RCS |
|---|---|---|
| Relative Strength Index (RSI) | 42.93 | 40.44 |
| Support Level | $9.65 | $5.10 |
| Resistance Level | $9.89 | $5.67 |
| Average True Range (ATR) | 0.09 | 0.06 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 32.00 | 7.14 |
Price Performance
Historical Comparison NPCT
RCS
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to provide a high level of current income.
About RCS PIMCO Strategic Income Fund Inc.
PIMCO Strategic Income Fund, Inc. operates as a closed-end management investment company. Its primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities. The Fund also seeks capital appreciation to the extent consistent with the objective.